Shanghai Haohai Biological Technology Co., Ltd. (Haohai Biotec, stock code: 06826) has announced that its board of directors will convene on 20 March 2026 in Shanghai. The meeting’s agenda includes approval and publication of the consolidated annual results for the financial year ended 31 December 2025, as well as consideration of a final dividend recommendation.

The board currently comprises four executive directors (Dr. Hou Yongtai, Mr. Wu Jianying, Ms. Chen Yiyi, Mr. Tang Minjie), three non-executive directors (Ms. You Jie, Mr. Huang Ming, Mr. Wei Changzheng) and four independent non-executive directors (Mr. Shen Hongbo, Mr. Jiang Zhihong, Mr. Su Zhi, Mr. Yang Yushe). The meeting will be chaired by Dr. Hou Yongtai.